OncoSil Medical LtdASX: OSL

Peer-Reviewed Study Reports 100% Disease Control

· Issued by OncoSil Medical Ltd via ASX

Filed with ASX · · 3 pages · English

Release

ASX Announcement 27 October 2026 OncoSil™ Study Reports 100% Local Disease Control and Promising Surgical Outcomes in Locally Advanced Pancreatic Cancer Key highlights • Peer-reviewed clinical study published in the international oncology journal Cancers, reporting early outcomes in 17 patients...

OncoSil Medical Ltd on 6ix

Earlier from OncoSil Medical

Later from OncoSil Medical

All OncoSil Medical news releases